Last reviewed · How we verify

NCT06809985: DEMEM

Latent Phase Membrane Stripping for Caesarean Section Reduction

Completed NA Last updated 4 December 2025
What this trial tests

NA trial testing Hamilton maneuver in Cesarean Delivery in 71 participants. Completed in 1 September 2025.

Timeline
31 January 2025
Primary endpoint
31 July 2025
1 September 2025

Quick facts

Lead sponsorRicardo A Gutierrez Ramirez, MD, MSc, FACOG
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposeprevention
Enrollment71
Start date31 January 2025
Primary completion31 July 2025
Estimated completion1 September 2025
Sites1 location across Honduras

Drugs / interventions tested

Conditions studied

Sponsor

Ricardo A Gutierrez Ramirez, MD, MSc, FACOG — full company profile →

Who can join

Adults 18 to 45, female only, with Cesarean Delivery or Cervical Ripening. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

In the Hospital Escuela, the availability of beds and criteria for admission to the intensive care unit ICU are not the same, the use of this marker is questionable, as it is affected by the level of complexity of care provided to a health setting and the organization of obstetric care. The cesarean section rate (almost 63.2%), is without significant variation by different criteria. The importance of finding strategies to reduce the rate of cesarean births and thus counteract the high rates of maternal morbidity and mortality is proposed. For this reason, this research is aimed at reducing the latent phase of labor through the use of the Hamilton maneuver.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Cesarean Delivery

Currently open trials in the same condition.

Other Ricardo A Gutierrez Ramirez, MD, MSc, FACOG trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06809985.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing